ニュース

FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and ...
The FDA will now limit seasonal COVID shots to seniors over 65, high-risk individuals, and young children—ending broad ...
Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
健康な成人と子どもを対象とした新型コロナウイルス感染症のブースター接種について、米規制当局は今後、新たな臨床試験で安全性と有効性が確認されることを承認の条件とする。コストのかかる新要件が追加され、将来的にはワクチン接種対象者が絞られる可能性もある。
The US Food and Drug Administration (FDA) announced today that it will only recommend COVID-19 vaccines for adults 65 and ...
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
With new testing requirements, it’s not even clear whether new Covid or flu shots can be made available this fall.